UK markets close in 1 hour 43 minutes

Acurx Pharmaceuticals, Inc. (ACXP)

NasdaqCM - NasdaqCM Real-time price. Currency in USD
Add to watchlist
1.7288+0.0938 (+5.53%)
As of 09:45AM EDT. Market open.
Show:
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
Total revenue
0
0
0
0
0
Operating expenses
Research development
4,038
6,044
4,754
2,030
2,203
Selling general and administrative
7,422
8,534
7,339
10,784
2,397
Total operating expenses
11,459
14,578
12,093
12,814
4,600
Operating income or loss
-11,459
-14,578
-12,093
-12,814
-4,600
Total other income/expenses net
-
-
-
66.503
-
Income before tax
-11,459
-14,578
-12,093
-12,748
-4,600
Income from continuing operations
-11,459
-14,578
-12,093
-12,748
-4,600
Net income
-11,459
-14,578
-12,093
-12,748
-4,600
Net income available to common shareholders
-11,459
-14,578
-12,093
-12,748
-4,600
Basic EPS
-1.05
-
-1.12
-1.49
-0.48
Diluted EPS
-1.05
-
-1.12
-1.49
-0.48
Basic average shares
12,114
-
10,816
8,536
9,541
Diluted average shares
12,114
-
10,816
8,536
9,541